In a groundbreaking development poised to transform the landscape of nuclear medicine, scientists have unveiled an innovative method for producing one of the most crucial medical isotopes: molybdenum-99 (^99Mo). Currently, the global supply of ^99Mo—a cornerstone radionuclide used in diagnostic imaging—is largely dependent on aging reactors, a reliance fraught with challenges including supply chain vulnerabilities, geopolitical tensions, and significant radioactive waste generation. The newly proposed technique circumvents these issues by harnessing cutting-edge electron accelerator technology to induce photofission in molten salt targets enriched with natural uranium, marking a paradigm shift in isotope production strategies.
At the heart of this novel approach is the utilization of high-energy electron beams directed towards a continuously flowing molten salt target containing natural uranium. When these high-energy electrons penetrate the target medium, they generate intense bremsstrahlung photon fields capable of initiating photofission reactions predominantly in ^238U. Unlike traditional methods reliant on the fissile isotope ^235U, this technique leverages the more abundant ^238U isotope, substantially mitigating proliferation risks associated with fissile materials and enabling direct utilization of naturally occurring or depleted uranium sources. This intrinsic material security advantage addresses long-standing concerns over nuclear material handling in isotope production.
The photofission mechanism driving ^99Mo synthesis in this system capitalizes on the interaction of bremsstrahlung photons with uranium nuclei, leading to fission events that produce a variety of fission products, including ^99Mo. The comparable photofission cross-sections of ^238U and ^235U ensure efficient isotope generation without the need for fissile enrichment. Although the overall production rate of ^99Mo through photofission is empirically lower than reactor-based fission of enriched uranium targets, the safety, sustainability, and geopolitical benefits render this trade-off highly favorable. As leading nuclear scientists observe, the methodology offers a safer pathway with fewer proliferation and waste concerns that could redefine the operational framework of medical isotope supply chains.
Critical to the success of this technology is the engineering and material optimization underpinning the molten salt target system. After comprehensive computational simulations and parametric studies, fluoride-based molten salts were identified as optimal due to their high bremsstrahlung photon yield and superior energy absorption characteristics. These salts not only facilitate efficient energy transfer from electron beams but also provide excellent chemical stability and thermal conductivity essential for withstanding intense irradiation conditions. This molten salt flow system dynamically dissipates heat, preventing localized hotspots and phase changes that could jeopardize target integrity and consistent isotope yield.
The electron beam parameters themselves have been meticulously optimized to maximize production efficiency while maintaining target integrity. An energy range between 40 to 80 MeV has been pinpointed as ideal, balancing the need for sufficient photon flux generation with engineering constraints related to accelerator design and power consumption. When these electron beams interact with the uranium-bearing molten salt, a photon field intense enough to sustain meaningful photofission rates emerges, affirming the feasibility of scalable isotope production beyond theoretical confines.
Another pivotal aspect addressed by the research is thermal management. Advanced temperature field analyses of the flowing molten salt demonstrate effective heat removal capabilities, which preclude boiling or undue thermal stress within the target system. This confirms the technical viability of continuous operation under realistic industrial conditions, bolstering confidence in deploying such systems for commercial ^99Mo production. The fluid dynamics and heat transfer properties inherent to molten salt flow act synergistically to maintain operational stability under high-dose irradiation.
This approach’s scalability benchmarks are particularly impressive. Projections estimate that a single system could annually produce around 4486.49 curies of ^99Mo, enough to facilitate several hundred thousand to over a million diagnostic imaging procedures. In the context of China’s projected demand for ^99Mo by 2030, this technology has the potential to supply approximately 16.37% of national requirements, signaling its role not only as a complementary source but also as a disruptive game-changer in isotope availability. Distributed implementation of modular molten salt photofission units could decentralize production and reduce dependency on external suppliers.
Beyond its production capacity, this innovative route integrates advances in electron accelerator technology with molten salt chemistry, signaling a new wave in nuclear isotope production methodologies. It addresses long-standing issues related to nuclear proliferation, radioactive waste generation, and reactor dependency while equipping countries with the technological foundations to establish regional production hubs. Such decentralization enhances the resilience and security of nuclear medicine supply chains, ultimately benefiting patient care worldwide by ensuring uninterrupted access to crucial diagnostic agents.
Notably, the scientific community acknowledges that while photofission-generated ^99Mo currently yields lower activity levels compared to reactor fission, its safer material profile and reduced regulatory hurdles offer unmatched long-term sustainability advantages. Its reliance on non-enriched uranium broadens the accessibility of isotope production technologies, potentially stimulating broader adoption across nations lacking extensive nuclear infrastructure. This democratization of isotope production aligns with global health objectives by improving diagnostic capacities in underserved regions.
The engineering achievements underlying the flowing molten salt target system evoke particular interest. The continuous flow mechanism ensures prompt removal of fission products and thermal stresses, vital for maintaining stable isotope output rates. This dynamic environment contrasts with static target designs, affording enhanced control over irradiation conditions and target longevity. Furthermore, the physical and chemical stability of fluoride salts under intense radiation facilitates prolonged operational lifespans with reduced maintenance intervals, fortifying the method’s industrial appeal.
Integral to the advancement of this technique has been the use of comprehensive computational modeling, enabling precise simulation of photofission yields, heat transfer dynamics, and electron beam-target interactions. These simulations have guided parameter optimizations and risk assessments, fostering design iterations that reconcile theoretical efficiency with practical safety considerations. Such rigorous modeling supports the translation of laboratory-scale concepts into robust industrial-scale isotope production platforms.
As global demand for medical isotopes continues rising, driven by increased diagnostic imaging and therapeutic applications, innovations like this electron-irradiated molten salt photofission method represent a critical step forward. By leveraging nuclear physics principles within a sustainable engineering framework, the approach exemplifies how multi-disciplinary research can converge to address pressing healthcare supply challenges. The societal benefits extend beyond medical diagnostics, enhancing national security, minimizing radioactive waste, and promoting environmentally responsible nuclear technology applications.
In summary, this pioneering method for ^99Mo production ushers in a transformative era for nuclear medicine isotope supply. It offers enhanced safety, reduced proliferation concerns, and the promise of scalable, decentralized isotope generation. Researchers are optimistic that continued development and eventual deployment of this technology will fortify the resilience and sustainability of medical isotope supply chains worldwide. As attention turns to practical implementation, future work will focus on prototype validation, cost-effectiveness analyses, and regulatory pathway navigation to unlock the full potential of this promising innovation.
Subject of Research: Not applicable
Article Title: Production of 99Mo via photofission reaction in natural-uranium-bearing molten salt targets
News Publication Date: 9-Feb-2026
Web References: 10.1007/s41365-026-01908-3
Image Credits: Xiao-Xiao Li
Keywords: Nuclear physics, Radiation therapy
